Trials / Conditions / Metastatic Non-small Cell Lung Cancer (NSCLC)
Metastatic Non-small Cell Lung Cancer (NSCLC)
5 registered clinical trials studyying Metastatic Non-small Cell Lung Cancer (NSCLC) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophospham NCT07130032 | EuroCityClinic LLC | Phase 2 |
| Withdrawn | A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cance NCT04466917 | Amgen | Phase 3 |
| Active Not Recruiting | A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC NCT03819465 | AstraZeneca | Phase 1 |
| Completed | UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients NCT03158883 | Megan Daly, MD | EARLY_Phase 1 |
| Recruiting | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Pa NCT02622581 | AIO-Studien-gGmbH | — |